Dow Jones 30 Stocks SEC Filings — October 14, 2026

EVP & CFO Amy Hood sold ~7,305 shares in three tranches ($544.80, $545.77, $546.51) totaling roughly $3.99M, executed under a Rule 10b5-1 plan; she retains ~555,396 shares, so the sale is small relative to holdings and plan-driven

Eleven directors each received a 1,438-share common stock award, a uniform grant pattern pointing to a standard annual director compensation cycle with no discretionary signal

Board-level equity alignment is broad-based: post-award holdings range from ~4,474 (Arnold) to ~38,968 (Jimenez) shares, indicating meaningful director ownership across the board

No director sales or pledges appeared in the filings, so insider activity at P&G shows no distribution pressure in this window

The CFO's sales occurred at a tight price band ($544.80-$546.51), suggesting orderly execution under the plan rather than an opportunistic exit into strength

Chang Amy (~18,897 shares) and McCarthy Christine M (~19,342 shares) hold among the largest post-award director positions, reinforcing long-tenured board alignment

CFO sold ~$3.99M of stock across three same-day tranches; although executed under a 10b5-1 plan, the cluster of sales is worth monitoring if followed by additional executive dispositions

None of the 12 filings contain period-over-period revenue, margin, or guidance data, so fundamental deterioration (or improvement) cannot be assessed from this batch

Uniform director grants with neutral sentiment offer no evidence of insider conviction either way; the absence of open-market director purchases in the window is a mild non-signal worth noting

Eleven directors holding a combined ~150,000+ shares after grants supports governance alignment with long-term shareholders, a supportive backdrop for the stock

Because the CFO's sale is a Rule 10b5-1 transaction with a retained stake of ~555K shares, the event reflects personal diversification rather than a thesis change, leaving the investment case intact for those tracking the name

The synchronized 1,438-share grant across the full board marks a predictable annual cadence, allowing investors to anticipate a repeat award in the next compensation cycle without inferring change

All P&G director filings reflect an identical 1,438-share award, pointing to a formulaic equity-retainer structure that signals stable, rules-based governance rather than discretionary capital allocation shifts

Microsoft's CFO sale was executed under a pre-arranged plan, consistent with the broader large-cap practice of scheduling executive dispositions to reduce signaling risk; investors should therefore weight plan-based sales less heavily than discretionary ones

Track whether further Form 4 filings show additional 10b5-1 sales or a change in plan cadence; the next scheduled earnings report will provide context on any trading-plan disclosures

Monitor for any open-market director purchases or sales following the annual award; none were observed in this batch

Watch the upcoming 10-Q for operating metrics, margin trends, and guidance, which this insider-focused batch does not capture

Review the next 10-Q and earnings call for period-over-period revenue, cloud growth, and margin commentary to contextualize the CFO's sales

Watch for additional executive sales across other Dow constituents in the coming weeks; clustering would be more informative than isolated plan-based transactions

Track any director changes or new appointments reflected in future Form 3/4 filings, as the current batch shows a stable 11-director roster